QDEL: QuidelOrtho Corporation - Summary | Jitta

QuidelOrtho Corporation

NASDAQ:QDEL

Price
$89.70
Loss Chance
42.1%
6.13JITTA SCORE
79.77%Under Jitta Line
Jitta Ranking
66 / 1,189
1,059 / 4,967
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (60)
Recent Business Performance (49)
Financial Strength (90)
Return to Shareholders (48)
Competitive Advantage (67)
Jitta Signs
Debt LevelLow Long Term Debt
Interest Coverage RatioGood
SG&A to SalesDecreasing
Revenue and EarningEarning loss detected in 2016
Operating MarginDeclined
Recent Business PerformanceEarning decline 86.19% in the last quarter (yoy)
Key Stats
Jitta Score
Jitta Line
6.13
79.77%
2.00
228.54%
Health Care Equipment
5.40
190.24%
6.94
124.04%
6.13
9.30%
COMPANY DESCRIPTION
QuidelOrtho Corporation focuses on the development and manufacture of diagnostic testing technologies across the continuum of healthcare testing needs. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, which measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease, or markers of proper organ function and health; testing products to detect and monitor disease progression across a spectrum of therapeutic areas; and specialized diagnostic solutions. The Transfusion Medicine business unit offers immunohematology instruments and tests used for blood typing to ensure patient-donor compatibility in blood transfusions; and donor screening instruments and tests used for blood and plasma screening for infectious diseases. The Point-of-Care business unit provides tests to provide rapid results across a continuum of point-of-care settings. The Molecular Diagnostics business unit offers polymerase chain reaction thermocyclers; and analyzers and amplification systems. The company sells its products directly to end users through a direct sales force; and through a network of distributors for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, blood banks, and donor centers, as well as for individual, non-professional, and over-the-counter use. It operates in North America, Europe, the Middle East, Africa, China, and internationally. The company was founded in 1979 and is headquartered in San Diego, California.